1. Andrew Rambaut, et al. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. Genomics Consortium UK (CoG-UK), December 19, 2020.
2. Hoffmann et al. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells, 2020, Molecular Cell 78, 779–784, May 21, 2020.
3. Gu et al. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy, Science 369, 1603–1607 (2020).
4. Starr et al. Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding , 2020, Cell 182, 1295–1310, September 3, 2020.
5. Kevin R. McCarthy et al. Natural deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. bioRxiv, December 19, 2020.
6. Kemp SA, et al. Neutralising antibodies drive Spike mediated SARS-CoV-2 evasion. medRxiv, December 19, 2020.
7. Thomas P. Peacock, et al. The furin cleavage site of SARS-CoV-2 spike protein is a key determinant for transmission due to enhanced replication in airway cells. bioRxiv, September 30, 2020.
8. Yunkai Zhu, et al. The S1/S2 boundary of SARS-CoV-2 spike protein modulates cellentry pathways and transmission. bioRxiv, August 25, 2020.